Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets
Open Access
- 14 July 2023
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 7 (14) , 3561-3572
Abstract
Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor–triggered macrophage phagocytosis of platelets using specimens from patients with ITP. Here, we assessed sera from a cohort of 24 patients with ITP for the capacity to trigger macrophage phagocytosis of normal donor platelets and characterized the contribution of humoral factors to phagocytosis. Sera that produced a phagocytosis magnitude greater than a normal human serum mean + 2 standard deviations were considered phagocytosis-positive. Overall, 42% (8/19) of MHC I alloantibody-negative ITP sera were phagocytosis-positive. The indirect monoclonal antibody immobilization of platelet antigens assay was used to detect immunoglobulin G (IgG) autoantibodies to glycoproteins (GP)IIb/IIIa, GPIb/IX, and GPIa/IIa. Autoantibody-positive sera triggered a higher mean magnitude of phagocytosis than autoantibody-negative sera. Phagocytosis correlated inversely with platelet counts among autoantibody-positive patients but not among autoantibody-negative patients. Select phagocytosis-positive sera were separated into IgG-purified and -depleted fractions via protein G and reassessed for phagocytosis. Phagocytosis was largely retained in the purified IgG fractions. In addition, we assessed serum concentrations of C-reactive protein, serum amyloid P, and pentraxin 3 as potential phagocytosis modulators. Pentraxin 3 concentrations correlated inversely with platelet counts among patients positive for autoantibodies. Taken together, sera from approximately half of the patients with ITP studied triggered macrophage phagocytosis of platelets beyond a normal level. An important role for antiplatelet autoantibodies in phagocytosis is supported; a role for pentraxins such as pentraxin 3 may be suggested.Keywords
This publication has 43 references indexed in Scilit:
- Autoantibody‐mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)European Journal of Haematology, 2011
- The Isotype of Autoantibodies Influences the Phagocytosis of Antibody‐Coated Platelets in Autoimmune Thrombocytopenic PurpuraScandinavian Journal of Immunology, 2011
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002
- Autoantibodies against platelet glycoprotein Ib/IX: a frequent finding in autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 1991
- Platelet‐associated complement in chronic ITPBritish Journal of Haematology, 1985
- In vitro Platelet Phagocytosis in Idiopathic Thrombocytopenic PurpuraActa Haematologica, 1983
- Phagocytosis of Antibody-Coated Platelets by Human GranulocytesNew England Journal of Medicine, 1974
- In Vitro Platelet Phagocytosis by Splenic Leukocytes in Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1974
- SIMILARITIES BETWEEN KNOWN ANTIPLATELET ANTIBODIES AND THE FACTOR RESPONSIBLE FOR THROMBOCYTOPENIA IN IDIOPATHIC PURPURA. PHYSIOLOGIC, SEROLOGIC AND ISOTOPIC STUDIESAnnals of the New York Academy of Sciences, 1965
- IMMUNOLOGIC MECHANISMS IN IDIOPATHIC AND NEONATAL THROMBOCYTOPENIC PURPURAAnnals of Internal Medicine, 1953